Skip to content
Screener

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$923M-16.5%
ADMA Biologics logo
ADMA BiologicsADMA
$27.28M+45.8%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$138.1M-3.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$1.76M+73.4%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.61M-35.5%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$148.62M-12.2%

Other financials

Income statement

See full
Revenue$34.2M
Gross profit$12.1M
Operating income$2.6M
Net income-$6.2M
EPS (diluted)-$0.19

Balance sheet

See full
Cash & equivalents$17.2M
Total debt$8.1M
Total equity-$34.1M-3,860%
Total assets$229.5M

Cash flow

See full
Operating cash flow$2.5M
CapEx$1.6M

Valuation

See full
Market cap$176.02M-37.5%
Enterprise value$166.84M+9.7%
P/S1.4×+0.4×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-13.4%
Net margin-30%
FCF margin-31.8%+460pp

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

The source filing: Lifecore Biomedical, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 7:20 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q3 2026
Accession
0001005286-26-000033

FAQ

What is Lifecore Biomedical, Inc.'s free cash flow?
Lifecore Biomedical, Inc. (LFCR) reported free cash flow of $880K in Q2 2026.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Lifecore Biomedical, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude